Bolt Biotherapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Redwood City, CA
BOLT chart
What traders are saying about $BOLT
Latest postsBolt Biotherapeutics, Inc. news
- Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Beats Revenue Estimates
Yahoo Finance ·
- Adaptive Biotechnologies (ADPT) Q3 Earnings and Revenues Top Estimates
Yahoo Finance ·
- BOLT Q3'26 Earnings: EPS estimate is (3.69) USD
TradingView ·
- INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - RRC, SGRY, BOLT and PCRX - IS IT A FAIR DEAL FOR YOU?
Morningstar ·
- Bolt Biotherapeutics to Participate in Upcoming Conferences
Yahoo Finance ·
- Lilly shuffles business structure; Novartis writes off part of Avidity deal
biopharmadive.com ·
- Bolt Biotherapeutics Announces Acquisition of Prana Therapies and $120 Million Concurrent Private Placement to Advance PRA-216 in Multiple High-Value Inflammatory Indications
Yahoo Finance ·
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates
Yahoo Finance ·
- Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Bolt Metals Announces Closing of Option to Acquire the High-Grade Floralia Iron Project
Yahoo Finance ·
- Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted Treatments | DelveInsight
Yahoo Finance ·
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates
Yahoo Finance ·
Bolt Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.7M | $7.7M | $7.9M | $5.7M |
| Net income | -$33.4M | -$63.1M | -$69.2M | -$88.1M |
| Diluted EPS | $-17.85 | $-33.06 | $-1.83 | $-2.36 |
| Total assets (year end) | $56.7M | $99.6M | $159.8M | $227.8M |
| Cash and equivalents (year end) | $11.7M | $7.2M | $10.8M | $9.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Bolt Biotherapeutics, Inc.
- Ticker
- BOLT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1641281
- Former names
- Bolt Therapeutics, Inc.
Frequently asked questions
What exchange is Bolt Biotherapeutics, Inc. listed on?
Bolt Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol BOLT.
What industry is Bolt Biotherapeutics, Inc. in?
Bolt Biotherapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Bolt Biotherapeutics, Inc. headquartered?
Bolt Biotherapeutics, Inc.'s business address on file with the SEC is in Redwood City, CA.
When does Bolt Biotherapeutics, Inc.'s fiscal year end?
Bolt Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Bolt Biotherapeutics, Inc. report?
Bolt Biotherapeutics, Inc. reported $7.7M in revenue for calendar year 2025, according to its SEC filings.